New patent for Amneal drug LYVISPAH

Annual Drug Patent Expirations for LYVISPAH Lyvispah is a drug marketed by Amneal and is included in one NDA. It is available from two suppliers. There are four patents protecting…

Source


Comments are closed.

Biotechblog